Versant Capital Management, Inc Cv Rx, Inc. Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in Cv Rx, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 255 shares of CVRX stock, worth $2,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
255Holding current value
$2,129% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CVRX
# of Institutions
102Shares Held
16.3MCall Options Held
53.4KPut Options Held
32.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$34.3 Million16.67% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$16.9 Million2.35% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT1.23MShares$10.3 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$8.41 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.31 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $172M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...